Exenatide Improves Glycemic Control and Reduces Body Weight in Subjects with Type 2 Diabetes: A Dose-Ranging Study
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institution: Eli Lilly (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, type 2 diabetes, incretin mimetics, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, weight loss, dose dependence, metformin, diet and exercise, drug tolerability, adverse events, nausea, vomiting, hypoglycemia, pharmacokinetics, pharmacodynamics, glucagon-like peptide-1
Open Access status: closed
OpenAlex ID: W1964478407
